ROTH.US Pharmaroth Labs Inc

Healthcare Biotechnology USA Stocks
0.0000 USD
Close of Oct 13, 2026
Market cap
USD 1.49K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Dec 2017.

Is ROTH.US undervalued?

Graham number

The Graham number of Pharmaroth Labs Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmaroth Labs Inc fundamental analysis

No fundamental analysis for Pharmaroth Labs Inc yet.

Pharmaroth Labs Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmaroth Labs Inc

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.

Full company profile